Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000102 · ClinicalTrials.gov registry record · Phase 1
Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
A Phase 1 study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00000102: Completed Phase 1 study, sponsored by National Center for Research Resources (NCRR).
NCT00000102 is a Phase 1 study that has completed, run by National Center for Research Resources (NCRR). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000102, a Phase 1 study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
This study will test the ability of extended release nifedipine (Procardia XL), a blood pressure medication, to permit a decrease in the dose of glucocorticoid medication children take to treat congenital adrenal hyperplasia (CAH).
Interventions
- DRUG Nifedipine
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00000102 record still lists
NCT00000102 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Nifedipine is the first listed.
NCT00000102 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000102 about?
NCT00000102 is a clinical study titled "Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets". This study will test the ability of extended release nifedipine (Procardia XL), a blood pressure medication, to permit a decrease in the dose of glucocorticoid medication children take to treat congenital adrenal hyperplasia (CAH).
What is the current status of trial NCT00000102?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00000102?
The interventions under investigation include: Nifedipine (DRUG).
Who is sponsoring clinical trial NCT00000102?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.